Healthcare Professional Resources
Resources to Support Neuroendocrine Cancer Care
Access trusted, evidence-based materials to support the diagnosis, treatment, and management of neuroendocrine cancer in clinical practice.
Alternatively, you can order printed resources here.
Filter by:
Or browse by
popular tag:
Advocacy & Awareness Videos
NeuroEndocrine Cancer Australia Thankyou Video
HCP Videos
Neuroendocrine Cancer Symptoms: Full Interview with Dr David Chan
HCP Videos
Neuroendocrine Cancer Symptoms: Full Interview with Dr John Leyden
HCP Videos
Neuroendocrine Cancer Symptoms: Full Interview with Prof Nick Pavlakis
HCP Videos
Neuroendocrine Cancer Symptoms: Specialist interview: Dr Bill Macdonald and Dr David Ransom
HCP Videos
Neuroendocrine Cancer Symptoms: With Dr Gabrielle Cehic AM
HCP Videos
Neuroendocrine Cancer Symptoms: With Meredith Cummins
Courses
Neuroendocrine Tumour Education Course
Booklets & Guides
Neuroendocrine tumours: A guide for healthcare professionals
Clinical Trials
ONJCRI Immunotherapy Trial: Nivolumab & Ipilimumab for Rare and Advanced Cancers
This protocol provides an important opportunity to establish whether the combination of nivolumab & ipilimumab has efficacy in these cancers.
Educational Videos
Optimal Care Pathway for Neuroendocrine Tumours (NETs)
Clinical Trials
PARP Inhibitor With 177Lu-DOTA-Octreotate PRRT in Patients With Neuroendocrine Tumours (PARLuNET)
PARLuNET is a phase 1 dose-escalation study designed to evaluate the safety and tolerability of talazoparib (PARP Inhibitor) in...
Other Resources
Patient Card – Medical Alert
Clinical Trials
Phase 3 Trial of CAM2029 vs Standard Treatments in GEP-NET Patients
The purpose of this study is to compare the effectiveness and safety of CAM2029 to octreotide LAR or lanreotide ATG in patients with advanced, well-differentiated GEP-NET.
Fact Sheets